Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?

<h4>Background</h4>Individuals with previous syphilis may experience cognitive impairment. The goal of this study was to determine if those at high risk for laboratory-defined neurosyphilis are cognitively impaired, and whether treatment based on cerebrospinal fluid (CSF) findings result...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arielle P Davis, Clare L Maxwell, Haley Mendoza, Abby Crooks, Shelia B Dunaway, Sher Storey, Claire Stevens, Lauren C Tantalo, Sharon K Sahi, Kevin R Robertson, Christina M Marra
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/17a2315d4e974a79b2938855e07e948a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:17a2315d4e974a79b2938855e07e948a
record_format dspace
spelling oai:doaj.org-article:17a2315d4e974a79b2938855e07e948a2021-12-02T20:15:25ZCognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?1932-620310.1371/journal.pone.0254518https://doaj.org/article/17a2315d4e974a79b2938855e07e948a2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254518https://doaj.org/toc/1932-6203<h4>Background</h4>Individuals with previous syphilis may experience cognitive impairment. The goal of this study was to determine if those at high risk for laboratory-defined neurosyphilis are cognitively impaired, and whether treatment based on cerebrospinal fluid (CSF) findings results in better outcomes.<h4>Methods</h4>Participants had a new syphilis diagnosis, serum RPR titer ≥ 1:32 or peripheral blood CD4+ T cells ≤ 350/ul (in persons living with HIV) and did not endorse neurological symptoms. They underwent computerized cognitive assessment with the CogState. Thirty-two were randomized to either undergo lumbar puncture (LP) or to not undergo LP and 14 underwent LP; 64 were not randomized and 48 opted to undergo LP.<h4>Results</h4>Demographics, cognitive complaints and cognitive impairment did not differ between randomized and nonrandomized participants. Two-thirds were cognitively impaired, and impairment was not more common in those with cognitive complaints. The adjusted odds of increased severity of impairment were 3.8 times greater in those with CSF pleocytosis compared to those without. Time to cognitive normalization, improvement or decline did not differ between those who did not undergo LP and those who underwent LP and whose treatment was based on CSF analysis. Taking into account pre-treatment cognitive impairment, the risk of cognitive decline was lower in those with CSF pleocytosis treated for neurosyphilis compared to those without CSF pleocytosis not treated for neurosyphilis, (HR 0.24 (95% CI 0.07-0.88], p = 0.03).<h4>Conclusion</h4>In individuals at high risk for laboratory-defined neurosyphilis, cognitive complaints are not a good indicator of cognitive impairment. Severity of cognitive impairment was greater in those with CSF pleocytosis. Identification and treatment of those with neurosyphilis may mitigate subsequent cognitive decline.Arielle P DavisClare L MaxwellHaley MendozaAbby CrooksShelia B DunawaySher StoreyClaire StevensLauren C TantaloSharon K SahiKevin R RobertsonChristina M MarraPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254518 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Arielle P Davis
Clare L Maxwell
Haley Mendoza
Abby Crooks
Shelia B Dunaway
Sher Storey
Claire Stevens
Lauren C Tantalo
Sharon K Sahi
Kevin R Robertson
Christina M Marra
Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
description <h4>Background</h4>Individuals with previous syphilis may experience cognitive impairment. The goal of this study was to determine if those at high risk for laboratory-defined neurosyphilis are cognitively impaired, and whether treatment based on cerebrospinal fluid (CSF) findings results in better outcomes.<h4>Methods</h4>Participants had a new syphilis diagnosis, serum RPR titer ≥ 1:32 or peripheral blood CD4+ T cells ≤ 350/ul (in persons living with HIV) and did not endorse neurological symptoms. They underwent computerized cognitive assessment with the CogState. Thirty-two were randomized to either undergo lumbar puncture (LP) or to not undergo LP and 14 underwent LP; 64 were not randomized and 48 opted to undergo LP.<h4>Results</h4>Demographics, cognitive complaints and cognitive impairment did not differ between randomized and nonrandomized participants. Two-thirds were cognitively impaired, and impairment was not more common in those with cognitive complaints. The adjusted odds of increased severity of impairment were 3.8 times greater in those with CSF pleocytosis compared to those without. Time to cognitive normalization, improvement or decline did not differ between those who did not undergo LP and those who underwent LP and whose treatment was based on CSF analysis. Taking into account pre-treatment cognitive impairment, the risk of cognitive decline was lower in those with CSF pleocytosis treated for neurosyphilis compared to those without CSF pleocytosis not treated for neurosyphilis, (HR 0.24 (95% CI 0.07-0.88], p = 0.03).<h4>Conclusion</h4>In individuals at high risk for laboratory-defined neurosyphilis, cognitive complaints are not a good indicator of cognitive impairment. Severity of cognitive impairment was greater in those with CSF pleocytosis. Identification and treatment of those with neurosyphilis may mitigate subsequent cognitive decline.
format article
author Arielle P Davis
Clare L Maxwell
Haley Mendoza
Abby Crooks
Shelia B Dunaway
Sher Storey
Claire Stevens
Lauren C Tantalo
Sharon K Sahi
Kevin R Robertson
Christina M Marra
author_facet Arielle P Davis
Clare L Maxwell
Haley Mendoza
Abby Crooks
Shelia B Dunaway
Sher Storey
Claire Stevens
Lauren C Tantalo
Sharon K Sahi
Kevin R Robertson
Christina M Marra
author_sort Arielle P Davis
title Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
title_short Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
title_full Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
title_fullStr Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
title_full_unstemmed Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
title_sort cognitive impairment in syphilis: does treatment based on cerebrospinal fluid analysis improve outcome?
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/17a2315d4e974a79b2938855e07e948a
work_keys_str_mv AT ariellepdavis cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT clarelmaxwell cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT haleymendoza cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT abbycrooks cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT sheliabdunaway cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT sherstorey cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT clairestevens cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT laurenctantalo cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT sharonksahi cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT kevinrrobertson cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
AT christinammarra cognitiveimpairmentinsyphilisdoestreatmentbasedoncerebrospinalfluidanalysisimproveoutcome
_version_ 1718374569350266880